Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Aug 26, 2023 11:43am
91 Views
Post# 35606693

RE:Question for Dan Carlson of Tailwinds

RE:Question for Dan Carlson of TailwindsIn October 2016, Bioasis engaged Rising Tide Equity, as the press release stated, to "Increase Global Awareness."

I think what impressed me, and likely Rob Hutchison, was that Rising Tide Equity was lead by Dr. Josh McGuire, former SERE Psychologist at the Department of Defense and Chief Psychologist, Competency Program, Texas Department of Health Services.

I was encouraged by RH to reach out to Dr. Josh McGuire but before I could, Rising Tide Equity broke up, with Dan Carlson forming Tailwinds Research Group and inheriting the Bioasis contract. Dr. McGuire had moved on.

I don't know the inside story on Rising Tide, McGuire, how Tailwinds got the contract, or much else. I do remember watching the BIOAF trading and there was virtually no change from normal.

Tailwinds Research Group didn't last very long. 

jd
<< Previous
Bullboard Posts
Next >>